Guardant Health (GH) Revenue (2017 - 2026)

Guardant Health has disclosed Revenue across 10 years of filings, most recently posting $335.0 million for Q2 2026.

• In Q2 2026, Revenue rose 44.33% year-over-year to $335.0 million; the TTM figure through Jun 2026 stood at $1.2 billion (up 42.74% YoY), while the FY2025 annual figure was $982.0 million, up 32.88% from the prior year.
• Revenue came in at $335.0 million for Q2 2026 at Guardant Health, up from $301.7 million in the prior quarter.
• In the past five years, Revenue ranged from a high of $335.0 million in Q2 2026 to a low of $96.1 million in Q1 2022.
• Average Revenue over 5 years is $187.3 million, with a median of $172.9 million recorded in 2024.
• Year-over-year, Revenue increased 17.37% in 2022 and soared 48.26% in 2026.
• Over 5 years, Revenue stood at $126.9 million in 2022, then gained by 22.19% to $155.1 million in 2023, then surged by 30.16% to $201.8 million in 2024, then jumped by 39.37% to $281.3 million in 2025, then increased by 19.1% to $335.0 million in 2026.
• Per Business Quant data, the three most recent Revenue figures were $335.0 million in Q2 2026, $301.7 million in Q1 2026, and $281.3 million in Q4 2025.